Trending...
- Love & Sip Valentine Brunch with Celebrity The Comedian, Tomea, Grammy Saxophonist Jason Davis, Gospel Contemporary Duo, Only God Ministries - 103
- The Bedside Report Webinar Slated To Help Future Nurses Rock
- Vaccine Update for Long Beach
IRVINE, Calif.--(BUSINESS WIRE)--Modulim, the global leader in optical imaging solutions for the non-invasive assessment of tissue and vascular health, announced today that Clarifi® has received CE Mark certification. This allows Modulim to now expand its marketing and distribution throughout Europe and apply for registration in other international markets that recognize the CE Mark.
Powered by Spatial Frequency Domain Imaging (SFDI), a patented optical imaging technology, Clarifi is the newest advancement for assessing tissue and microvascular function by quantitatively mapping tissue oxygenation and perfusion at the point-of-care. Clarifi's fully-integrated solution is rapidly gaining acceptance by clinicians across the continuum of care for assessing potential circulatory compromise to manage and treat diabetic, venous and pressure ulcers, acute and chronic wounds, burns, and amputations.
More on The Californer
"Obtaining CE marking for the Clarifi Imaging System is a key milestone for Modulim," said David Cuccia, Ph.D., Modulim's President and CTO. "This achievement allows us to expand our addressable market and deliver a complete microvascular assessment solution that helps clinicians prevent lower limb complications in patients with diabetes as well as other life-altering circulatory issues. We are now able to bring our innovative technology to our European clinical partners, and grow our ever expanding image library by reaching the 60 million diabetes patients in the EU."
Clarifi can help clinicians identify potential compromised circulation and pre-ulcerative conditions, before they are visible, so they can implement timely and targeted intervention to prevent costly and deadly complications. Powered by SFDI, Clarifi provides new information that enables healthcare providers in all environments to transition from reactive care to proactive care.
The Clarifi Imaging System demonstrates Modulim's continuing mission to deliver transformative optical solutions that help people live healthier, longer lives.
More on The Californer
About Modulim
Modulim delivers transformative optical solutions that help people live healthier, longer lives. Clarifi, powered by Spatial Frequency Domain Imaging (SFDI) technology, identifies compromised circulation at the point of care through non-contact rapid microvascular assessment of tissue. Clinicians and healthcare systems are empowered by SFDI images to make proactive, data-driven decisions in a multidisciplinary care setting, in order to reduce lower-limb complications caused by diabetes and peripheral arterial disease. Founded by the inventors of SFDI at the University of California Irvine, Modulim is based in Irvine, CA with a team dedicated to delivering powerful healthcare solutions that elevate and standardize health care delivery, while improving patient outcomes. Modulim is backed by Pangaea Ventures, Fresenius Medical Care Ventures, Grey Sky Venture Partners, Mitsubishi Capital, Hamamatsu Photonics, The Cove Fund at UCI Applied Innovation, and Fouse KK.
Clarifi is a registered trademark of Modulated Imaging (dba Modulim).
Powered by Spatial Frequency Domain Imaging (SFDI), a patented optical imaging technology, Clarifi is the newest advancement for assessing tissue and microvascular function by quantitatively mapping tissue oxygenation and perfusion at the point-of-care. Clarifi's fully-integrated solution is rapidly gaining acceptance by clinicians across the continuum of care for assessing potential circulatory compromise to manage and treat diabetic, venous and pressure ulcers, acute and chronic wounds, burns, and amputations.
More on The Californer
- Leon Youngblood Consultants streams Inaugural Concert featuring President Joe Biden & VP K. Harris
- PG&E Restores Nearly All Customers Following Historic Windstorm, Prepares for Winter Snow and Rain Next Week
- Ventura College's Advanced Manufacturing Program is Preparing for the Future
- Universal Credit now available for all your personal loan needs
- CEDC Awards Students with Fernandez Leadership Fund Scholarships
"Obtaining CE marking for the Clarifi Imaging System is a key milestone for Modulim," said David Cuccia, Ph.D., Modulim's President and CTO. "This achievement allows us to expand our addressable market and deliver a complete microvascular assessment solution that helps clinicians prevent lower limb complications in patients with diabetes as well as other life-altering circulatory issues. We are now able to bring our innovative technology to our European clinical partners, and grow our ever expanding image library by reaching the 60 million diabetes patients in the EU."
Clarifi can help clinicians identify potential compromised circulation and pre-ulcerative conditions, before they are visible, so they can implement timely and targeted intervention to prevent costly and deadly complications. Powered by SFDI, Clarifi provides new information that enables healthcare providers in all environments to transition from reactive care to proactive care.
The Clarifi Imaging System demonstrates Modulim's continuing mission to deliver transformative optical solutions that help people live healthier, longer lives.
More on The Californer
- Long Beach: LBC Vaccine Update
- San Jose: San José Mayor Sounds Warning as Another Silicon Valley Company Moves Headquarters
- The World's First Tortilla Chip Beer - Just in Time for Game Day
- FCPT Announces Tax Treatment of 2020 Distributions
- Furin Inhibitor Screening Kit (Fluorometric)
About Modulim
Modulim delivers transformative optical solutions that help people live healthier, longer lives. Clarifi, powered by Spatial Frequency Domain Imaging (SFDI) technology, identifies compromised circulation at the point of care through non-contact rapid microvascular assessment of tissue. Clinicians and healthcare systems are empowered by SFDI images to make proactive, data-driven decisions in a multidisciplinary care setting, in order to reduce lower-limb complications caused by diabetes and peripheral arterial disease. Founded by the inventors of SFDI at the University of California Irvine, Modulim is based in Irvine, CA with a team dedicated to delivering powerful healthcare solutions that elevate and standardize health care delivery, while improving patient outcomes. Modulim is backed by Pangaea Ventures, Fresenius Medical Care Ventures, Grey Sky Venture Partners, Mitsubishi Capital, Hamamatsu Photonics, The Cove Fund at UCI Applied Innovation, and Fouse KK.
Clarifi is a registered trademark of Modulated Imaging (dba Modulim).
Filed Under: Business
0 Comments
Latest on The Californer
- AECOM to host first quarter fiscal year 2021 earnings conference call on February 9th and host 2021 Investor Day on February 16th
- S'moresUp Integrates Google Classroom to Help Parents Monitor, Track and Automate Kids' Schoolwork Alongside Housework
- Social Music Platform, Geojam, announces new CMO
- Glancy Wine Education Foundation Announces Game-changing Donation from Wine Spectator Scholarship Foundation
- CORRECTING and REPLACING SHAREHOLDER ACTION ALERT: The Schall Law Firm Announces the Filing of a Class Action Lawsuit Against 9F Inc. and Encourages Investors with Losses in Excess of $100,000 to Contact the Firm
- California: Governor Newsom Announces Appointments 1.21.21
- Invitae Announces Pricing of Public Offering of Common Stock
- Silvergate Prices Follow-on Public Offering of Class A Common Stock
- Dynamic Healthcare Systems Now Integrates EHR with its Provider Analytics Solution
- Rock Out Kid Clothing Launches Kickstarter Campaign
- Beta-Glucan Assay Kit (Fluorometric)
- China Refuses to Accept Service of Berman Law Group's Coronavirus Class Action Complaint
- Love & Sip Valentine Brunch with Celebrity The Comedian, Tomea, Grammy Saxophonist Jason Davis, Gospel Contemporary Duo, Only God Ministries
- Connie Gohata Awarded Prestigious "Premier Luxury Marketing Consultant" Certification
- INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Tyson Foods, Inc. and Encourages Investors with Losses of $100,000 to Contact the Firm
- California: Governor Newsom Signs Executive Order in Response to COVID-19 Pandemic 1.21.21
- Wide Receiver, Kaleb Fossum, Signs With Frisco Fighters (IFL)
- San Francisco: Mayor London Breed Tours Brand New 203-Bed SAFE Navigation Center in the Bayview
- 2021 Southern California Super Lawyers Recognizes Three California Snell & Wilmer Partners
- Thakur Law Firm Founder and Managing Attorney Recognized as 2021 Southern California Super Lawyer